A double-blinded, controlled study of the efficacy, immunogenicity, safety and tolerability, and effectiveness of a pneumococcal conjugate vaccine containing.

Slides:



Advertisements
Similar presentations
Target Product Profile and technical requirements Pre-tender Meeting Pneumococcal Vaccines under the AMC Unicef Supply Division, Copenhagen 26 August.
Advertisements

Effect of Maternal Influenza Vaccination on Respiratory Disease among Infants Based on Protocol: Effect of Maternal Influenza Vaccination on Respiratory.
Correspondence between interracial births and multiple race reporting in the National Health Interview Survey Jennifer D. Parker Academy Health Annual.
Rotavirus vaccine impact. Introduction. Rotavirus vaccines lead to significant reductions in severe and fatal diarrhea in both vaccinated and unvaccinated.
Outbreak of Streptococcus pneumoniae in a Psychiatric Unit
MENINGOCOCCAL DISEASE AND VACCINATION CME/CNE October 2011 Public Health Unit/Immunisation Advisory Centre, University of Auckland.
Update on HPV analysis in the Aberdeen Area Delf Schmidt-Grimminger Assistant Professor The University of South Dakota.
Spiritual Values Among Older Native American Adults  Scott Kukar, Delitha Livingston, Laurel Mallett, Veronica Nieto Robin Bonifas, PhD, MSW Assistant.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Immunization Program Centers for Disease.
Hot Topics in Pediatric ID Robert J. Leggiadro, MD Chairman Department of Pediatrics Lincoln Medical Center Professor of Clinical Pediatrics Weill Medical.
Pandemic Influenza: Role and Responsibility of Local Public Health Richard M. Tooker, MD Chief Medical Officer Kalamazoo County Health and Community Services.
Institutional Review Boards (IRB) for Indian Health Research.
+ Preventing Influenza: Should Vaccinations Be Mandatory for hospital personnel? By: Denise Montero and Kristen Kubik.
Vaccines for Streptococcus pneumoniae 5 th ESCMID School Santander June 2006 Dr. José María Marimón. Hospital Donostia. Donostia-San Sebastián, Spain.
 1. Equal Access and Treatment  2. Appropriate AIVR Services  3. Impact of AIVR Services  4. Collaboration to Maximize Services 1.
Copyright © 2013 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 31 Health Supervision.
[Insert Long-term Care Facility Name Here] ? How can I Prevent Influenza At.
Seasonal and H1N1 Flu Guidance on helping Child Care and Early Childhood Programs respond to Influenza Season September 17, 2009 Presented by: Leona Davis.
TABLE OF CONTENTS CHAPTER 7.0: Community Health Indicators Chart 7.1: U.S. Population Trends and Projections by Age, Chart 7.2: U.S. Population.
Seasonal Flu Programme 2015/16 The Healthy Child Programme Public Health England NHS England Mersey Primary Head Teacher Presentation Summer
Local Public Health System Assessment using the NPHPSP Local Instrument Essential Service 6 Enforce Laws and Regulations that Protect Health and Ensure.
PUBLIC HEALTH DIVISION Immunization Program How can I prevent influenza at [Insert long-term care facility name here] Do no harm... Stick out your arm!
August 20, 2003 Focus Area 14: Immunization and Infectious Diseases Progress Review.
Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.
CDC’s Advisory Committee on Immunization Practices (ACIP) CDC’s Advisory Committee on Immunization Practices (ACIP) How is Vaccine Policy Made? William.
What is Research ? Research Methodology CHP400:
Indian Health Service Office of Environmental Health & Engineering Food Safety Updates By LCDR Sarah Snyder.
Strategic Issues in Vaccine Research (SIVR) Program Update, 2007 Ben Schwartz, NVPO NVAC June 2007.
Created byInformation Design A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes Robertino.
Modeling of the effect of pneumococcal conjugate vaccination on carriage and transmission of Streptococcus pneumoniae in Kenyan children John Ojal KEMRI-Wellcome.
1 Otitis Media Results from the Kaiser Permanente Efficacy Trial Steven Black, MD, Henry Shinefield, MD and Bruce Fireman, MS Kaiser Permanente Vaccine.
Clinical Trials and Research A Guide for Community Advisory Board Members Participant Manual.
Primary Immunogenicity Endpoints for New Infant Pneumococcal Conjugate Vaccines Vaccines and Related Biological Products Advisory Committee Meeting Lucia.
Inside Clinical Trials ® ALL RIGHTS RESERVED. What is a clinical trial? ALL RIGHTS RESERVED.
Group 1 NGO Group (Society for Family Support). Measles is one of the leading causes of death among young children even though a safe and cost- effective.
Community Health Worker Model by Linda Stone, CEO.
DISASTER PREPAREDNESS for Long-Term Care Facilities How and Why Do We Plan? Presented by William Whited State Long-Term Care Ombudsman.
 Carolyn A. Parry, MPH CDC Public Health Advisor Montana Immunization Program 2016 Regional Immunization Workshops.
Pneumococcal Vaccine Use Around the World: Successes and Challenges Adam L. Cohen, MD MPH Respiratory Diseases Branch, Division of Bacterial Diseases Centers.
Protecting Communities in Africa from Pneumococcus This resource has been developed by the Association for Science Education for their RCUK-funded series.
Health Promotion National Department of Health HEALTH PROMOTION AND DISEASE PREVENTION INFLUENZA VACCINATION CAMPAIGN 2015.
Value of PCR: A Pertussis Outbreak in a Football Team Sharmila Shah 1, Mohammed Haque 1, John Kornblum 2, Lillian Lee 2, Allison Scaccia 1, Jane R. Zucker.
Preventable Outbreak of Pneumococcal Pneumonia Among Unvaccinated Nursing Home Residents-- New Jersey, 2001 Tina Tan, MD CDC/EPO/State Branch New Jersey.
Date of download: 7/1/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Immunogenicity of 13-Valent Pneumococcal Conjugate.
Pneumococcal Disease and Pneumococcal Vaccines Epidemiology and Prevention of Vaccine- Preventable Diseases National Center for Immunization and Respiratory.
Sharing Immunization Data between IHS/Tribal Facilities and the Arizona State Immunization Information System Scott Hamstra, MD (IHS) Kimiko Gosney, MS.
Research Participant Satisfaction
Ear Health Research Program
Indirect effect of 10-valent pneumococcal vaccine on nasopharyngeal carriage in children under 2 years of age in a rural community in Pakistan Dr M Imran.
Vaccine Efficacy, Effectiveness and Impact
Overview.
The Ohio State University, Columbus, Ohio
Research Participant Satisfaction
Changes in pneumococcal serotypes and antibiotypes carried by vaccinated and unvaccinated day-care centre attendees in Portugal, a country with widespread.
Changes in antimicrobial resistance, serotypes and genotypes in Streptococcus pneumoniae over a 30-year period  J. Liñares, C. Ardanuy, R. Pallares, A.
Bridging to Bridges in Vaccine Development: Challenges in Comparing Multi-Serotype Vaccines – Jonathan Hartzel, Merck.
The State of Pneumococcal Disease Prevention
Pneumococcal Disease Prevention in Children: Issues in the Era of PCVs
Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era  S. Nunes,
Emergence of a serotype 1 Streptococcus pneumoniae lineage colonising healthy children in Portugal in the seven-valent conjugate vaccination era  S. Nunes,
Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage  Ron Dagan, Drora Fraser, Noga Givon, Pablo.
Surveillance for serious bacterial diseases
Changes in Streptococcus pneumoniae serotypes causing invasive disease with non- universal vaccination coverage of the seven-valent conjugate vaccine 
Clinical Microbiology and Infection
Impact of Prevnar13 on protecting against spread of disease
MenB Update: Communicating the Imperative With Parents
The Texas Child Care Immunization Assessment Survey
Invasive Pneumococcal Disease Serotypes After the Introduction of Pneumococcal Seven-Valent Conjugate Vaccine Arizona, Susan Goodykoontz, Daniel.
Presentation transcript:

A double-blinded, controlled study of the efficacy, immunogenicity, safety and tolerability, and effectiveness of a pneumococcal conjugate vaccine containing seven serotypes (6B, 14, 19F, 23F, 18C, 4 and 9V) compared to a control meningococcal c vaccine in Navajo and Apache Indian infants. (NNR.97.18) Long term impact of the pneumococcal conjugate vaccine on pneumococcal nasopharyngeal colonization and immune correlates for disease protection. (NNR ) Impact of 13-valent pneumococcal conjugate vaccine (PCV-13) on pneumococcal disease and colonization among Native American communities. (NNR ) Fifteen Years of Pneumococcal Carriage Studies among Navajo and White Mountain Apache Communities

Background

What are pneumococcal carriage studies? Pneumococcus lives in the back of the nose and throat (nasopharynx or NP)  this is called carriage Carriage always comes before disease

Why do we study “carriage” of pneumococcus? Identify the types of pneumococcus present in the population Describe patterns of disease transmission Identify antibiotic resistant pneumococcus strains This information can tell us… …the types of pneumococcus are most likely to cause disease.

Carriage Studies

How do we sample pneumococcus from the nasopharynx? A swab is inserted through the nose into the back of the nose/throat (nasopharynx or NP) This procedure does not hurt, but can tickle and make the eyes water. It is done quickly and in a continuous motion to minimize discomfort and avoid injury.

What carriage studies have been done? Original NPFamily NPLong-term NP PCV13 Impact Years conducted present Number participants Number households NP swab collection One per person Seven per person One per person Number NP swabs collected

Conduct of Carriage Studies

Who supports and approves our studies? Local community members Indian Health Service Navajo Nation IRB

Where do we enroll participants? Visit families at their home

We may also enroll participants in the clinic

How do we enroll participants? Participants consent to enroll into the study

What happens to the NP swabs? They are processed in the laboratory

How is pneumococcus isolated? 1. Pneumococcus from NP swab is grown on a blood-agar plate Colony of pneumococcus 2. Then, tests are run to determine the type of pneumococcus

Results of Carriage Studies

What can carriage studies tell us? Take Home Message #1: Carriage is most common among young children *Data from the Long-term NP study

*Data from the Original NP study and Long-term NP study Take Home Message #2: PCV7 reduces carriage of vaccine-type pneumococcus

*Data from the Family NP study Take Home Message #3: Vaccinating children can reduce vaccine-type carriage in unvaccinated family members

What can multiple carriage studies over time tell us? Percent of individuals with any type of pneumococcal carriage is unchanged over time

Future carriage study on Navajo Nation New type of vaccine on the horizon Targets all types of pneumococcus (not only 7 types or 13 types) May help to further reduce pneumococcal disease and carriage

Acknowledgements Participants from the Navajo and White Mountain Apache tribes Community members who supported these studies Nurses and research program assistants IRBs of the Navajo Nation, Phoenix Area IHS, and Johns Hopkins School of Public Health Indian Health Service providers, staff and facilities

Thank you!